NEW YORK, March 08, 2018 -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed in the United States District Court for the District of New Jersey against Riot Blockchain, Inc. (NASDAQ:RIOT) (“Riot”) on behalf of all shareholders who acquired shares from November 13, 2017 through February 15, 2018, both dates inclusive (“Class Period).
Investors who have incurred losses in Riot Blockchain, Inc. are urged to contact the firm immediately at [email protected] or (800) 575-0735 or (212) 545-4774. You may obtain additional information concerning the action on our website, www.whafh.com.
If you have incurred losses in the shares of Riot Blockchain, Inc. and would like to assist with the litigation process as a lead plaintiff, you may, no later than April 18, 2018, request that the Court appoint you lead plaintiff of the proposed class. Please contact Wolf Haldenstein to learn more about your rights as an investor in Riot Blockchain, Inc.
According to the filed lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that:
- Riot’s principle executive offices were not in Colorado, but rather in Florida in the same location as a large, influential shareholder, Barry C. Honig who had a previous working relationship with Defendant O’Rouke;
- Riot never intended to hold its Annual General Meetings scheduled for December 28, 2017 and February 1, 2018; and
- as a result, Defendants’ statements about Riot’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Shares of Riot Blockchain, Inc. presently trade close to 80% below the class period high of $46.20 reached on December 19, 2017.
Wolf Haldenstein Adler Freeman & Herz LLP has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys in various practice areas; and offices in New York, Chicago and San Diego. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation.
If you wish to discuss this action or have any questions regarding your rights and interests in this case, please immediately contact Wolf Haldenstein by telephone at (800) 575-0735, via e-mail at [email protected], or visit our website at www.whafh.com.
## Follow the firm and learn about newly filed cases on Twitter and Facebook. ##
Contact:
Wolf Haldenstein Adler Freeman & Herz LLP
Kevin Cooper, Esq.
Gregory Stone, Director of Case and Financial Analysis
Email: [email protected], [email protected] or [email protected]
Tel: (800) 575-0735 or (212) 545-4774
Attorney Advertising. Prior results do not guarantee or predict a similar outcome.


Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales
Jetstar to Charge for Overhead Cabin Bags From February
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
DHL Q2 Profit Jumps 24% as Express Business Drives Growth
SpaceX Targets Starship Flight 14 With First V3 Starlink Satellite Launch
Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback 



